Calcific aortic stenosis: an update

被引:126
作者
Rajamannan, Nalini M.
Bonow, Robert O.
Rahimtoola, Shahbudin H.
机构
[1] Univ So Calif, Los Angeles, CA 90033 USA
[2] Northwestern Univ, Feinberg Sch Med, Bluhm Cardiovasc Inst, Chicago, IL 60611 USA
[3] Northwestern Univ, Feinberg Sch Med, Div Cardiol, Chicago, IL 60611 USA
来源
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE | 2007年 / 4卷 / 05期
关键词
aortic stenosis; atherosclerosis; calcification; cellular mechanism; cholesterol;
D O I
10.1038/ncpcardio0827
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Calcific aortic stenosis in the elderly is the number one cause of surgical valve replacement in the US and Europe. The incidence of calcific aortic stenosis is increasing as the general age of the population increases. For many years, rheumatic heart disease was the main cause of aortic valve disease. Over the last half century, however, there has been a change from a rheumatic etiology to a 'degenerative' mechanism because of the increase in access to health care in developed countries and the increasing age of the population in the US and Europe. For many years 'degenerative' aortic stenosis was thought to be caused by the passive accumulation of calcium on the surface of the aortic valve leaflet. Recent studies have demonstrated, however, that the etiology of aortic valve disease has a similar pathophysiology to that of vascular atherosclerosis, and that the treatment of this disease could be similar to that of chronic vascular atherosclerosis. This Review will discuss our current understanding of the pathophysiology, risk factors, cellular mechanisms, diagnosis and finally, future medical therapies for calcific aortic stenosis.
引用
收藏
页码:254 / 262
页数:9
相关论文
共 64 条
[1]   CORRELATION OF SERUM-LIPIDS, CALCIUM, AND PHOSPHORUS, DIABETES-MELLITUS AND HISTORY OF SYSTEMIC HYPERTENSION WITH PRESENCE OR ABSENCE OF CALCIFIED OR THICKENED AORTIC CUSPS OR ROOT IN ELDERLY PATIENTS [J].
ARONOW, WS ;
SCHWARTZ, KS ;
KOENIGSBERG, M .
AMERICAN JOURNAL OF CARDIOLOGY, 1987, 59 (09) :998-999
[2]   Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons [J].
Aronow, WS ;
Ahn, C ;
Kronzon, I ;
Goldman, ME .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (06) :693-695
[3]   Apolipoproteins AI, B, and E polymorphisms in severe aortic valve stenosis [J].
Avakian, SD ;
Annicchino-Bizzacchi, JM ;
Grinberg, M ;
Ramires, JAF ;
Mansur, AP .
CLINICAL GENETICS, 2001, 60 (05) :381-384
[4]   Temporal variations in effective orifice area during ejection in patients with valvular aortic stenosis [J].
Beauchesne, LM ;
deKemp, R ;
Chan, KL ;
Burwash, IG .
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2003, 16 (09) :958-964
[5]   Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community [J].
Bellamy, MF ;
Pellikka, PA ;
Klarich, KW ;
Tajik, AJ ;
Enriquez-Sarano, M .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (10) :1723-1730
[6]   ACC/AHA 2006 guidelines for the management of patients with valvular heart disease [J].
Bonow, Robert O. ;
Carabello, Blase A. ;
Chatterjee, Kanu ;
de Leon, Antonio C., Jr. ;
Faxon, David P. ;
Freed, Michael D. ;
Gaasch, William H. ;
Lytle, Bruce Whitney ;
Nishimura, Rick A. ;
O'Gara, Patrick T. ;
O'Rourke, Robert A. ;
Otto, Catherine M. ;
Shah, Pravin M. ;
Shanewise, Jack S. ;
Smith, Sidney C., Jr. ;
Jacobs, Alice K. ;
Adams, Cynthia D. ;
Anderson, Jeffrey L. ;
Antman, Elliott M. ;
Faxon, David P. ;
Fuster, Valentin ;
Halperin, Jonathan L. ;
Hiratzka, Loren F. ;
Hunt, Sharon A. ;
Lytle, Bruce W. ;
Nishimura, Rick ;
Page, Richard L. ;
Riegel, Barbara .
CIRCULATION, 2006, 114 (05) :E84-E231
[7]   Contrast-enhanced cardiac magnetic resonance in the evaluation of myocardial infarction and myocardial viability in patients with ischemic heart disease [J].
Bucciarelli-Ducci, C ;
Wu, E ;
Lee, DC ;
Holly, TA ;
Klocke, FI ;
Bonow, R .
CURRENT PROBLEMS IN CARDIOLOGY, 2006, 31 (02) :128-168
[8]   Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation [J].
Caira, FC ;
Stock, SR ;
Gleason, TG ;
McGee, EC ;
Huang, J ;
Bonow, RO ;
Spelsberg, TC ;
McCarthy, PM ;
Rahimtoola, SH ;
Rajamannan, NM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (08) :1707-1712
[9]   Angiogenic activation of valvular endothelial cells in aortic valve stenosis [J].
Chalajour, F ;
Treede, H ;
Ebrahimnejad, A ;
Lauke, H ;
Reichenspurner, H ;
Ergun, S .
EXPERIMENTAL CELL RESEARCH, 2004, 298 (02) :455-464
[10]   A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis [J].
Cowell, SJ ;
Newby, DE ;
Prescott, RJ ;
Bloomfield, P ;
Reid, J ;
Northridge, DB ;
Boon, NA .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (23) :2389-2397